"Estriol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.
| Descriptor ID |
D004964
|
| MeSH Number(s) |
D04.210.500.365.415.331 D06.472.334.851.437.750
|
| Concept/Terms |
Estriol- Estriol
- 16alpha,17beta-Estriol
- 16alpha,17beta Estriol
- (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol
- 16-alpha-Hydroxy-Estradiol
- 16 alpha Hydroxy Estradiol
Epiestriol- Epiestriol
- 16beta-Hydroxy-Estradiol
- 16beta Hydroxy Estradiol
- (16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol
- Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol
|
Below are MeSH descriptors whose meaning is more general than "Estriol".
Below are MeSH descriptors whose meaning is more specific than "Estriol".
This graph shows the total number of publications written about "Estriol" by people in this website by year, and whether "Estriol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estriol" by people in Profiles.
-
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. Gynecol Oncol. 2022 03; 164(3):481-491.
-
Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo. Hum Reprod. 2018 11 01; 33(11):2131-2140.
-
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016 Jan; 15(1):35-46.
-
Treatment with an inhibitor of catechol-O-methyltransferase activity reduces preterm birth and impedes cervical resistance to stretch in pregnant rats. Reproduction. 2007 Dec; 134(6):831-9.
-
Estrogen metabolites and systolic blood pressure in a population-based sample of postmenopausal women. J Clin Endocrinol Metab. 2006 Mar; 91(3):1015-20.
-
Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome. Am J Obstet Gynecol. 2003 Sep; 189(3):755-7.
-
Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome. Acta Obstet Gynecol Scand. 1998 Jul; 77(6):609-13.
-
Biochemical markers of trisomy 21 in amniotic fluid. Prenat Diagn. 1997 Jan; 17(1):31-7.
-
[Comment on the contribution by Benz et al.: Serum screening for Down syndrome in women under 35 years of age with an age independent index]. Z Geburtshilfe Neonatol. 1995 May-Jun; 199(3):128-9.
-
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem. 1994 Sep; 31 ( Pt 5):447-54.